Abu Quora Hagar A, Zahra Maram H, El-Ghlban Samah, Nair Neha, Afify Said M, Hassan Ghmkin, Nawara Hend M, Sheta Mona, Monzur Sadia, Fu Xiaoying, Osman Amira, Seno Akimasa, Seno Masaharu
Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University Okayama 700-8530, Japan.
Cytology, Histology and Histochemistry, Zoology Department, Faculty of Science, Menoufia University Menoufia 32511, Egypt.
Am J Cancer Res. 2021 Jul 15;11(7):3475-3495. eCollection 2021.
Breast cancer is the first common cause of cancer-related death in women worldwide. Since the malignancy and aggressiveness of breast cancer have been correlated with the presence of breast cancer stem cells, the establishment of a disease model with cancer stem cells is required for the development of a novel therapeutic strategy. Here, we aimed to evaluate the availability of cancer stem cell models developed from mouse induced pluripotent stem cells with the conditioned medium of different subtypes of breast cancer cell lines, the hormonal-responsive T47D cell line and the triple-negative breast cancer BT549 cell line, to generate tumor models. When transplanted into the mammary fat pads of BALB/c nude mice, these two model cells formed malignant tumors exhibiting pronounced histopathological characteristics similar to breast cancers. Serial transplantation of the primary cultured cells into mammary fat pads evoked the same features of breast cancer, while this result was perturbed following subcutaneous transplantation. The tumors formed in the mammary fat pads exhibited immune reactivities to prolactin receptor, progesterone receptor, green florescent protein, Ki67, CD44, estrogen receptor α/β and cytokeratin 8, while all of the tumors and their derived primary cells exhibited immunoreactivity to estrogen receptor α/β and cytokeratin 8. Cancer stem cells can be developed from pluripotent stem cells via the secretory factors of cancer-derived cells with the capacity to inherit tissue specificity. However, cancer stem cells should be plastic enough to be affected by the microenvironment of specific tissues. In summary, we successfully established a breast cancer tumor model using mouse induced pluripotent stem cells developed from normal fibroblasts without genetic manipulation.
乳腺癌是全球女性癌症相关死亡的首要常见原因。由于乳腺癌的恶性程度和侵袭性与乳腺癌干细胞的存在相关,因此开发新型治疗策略需要建立具有癌症干细胞的疾病模型。在此,我们旨在评估由小鼠诱导多能干细胞与不同亚型乳腺癌细胞系(激素反应性T47D细胞系和三阴性乳腺癌BT549细胞系)的条件培养基所构建的癌症干细胞模型用于生成肿瘤模型的可行性。当将这两种模型细胞移植到BALB/c裸鼠的乳腺脂肪垫中时,它们形成了具有明显组织病理学特征的恶性肿瘤,类似于乳腺癌。将原代培养细胞连续移植到乳腺脂肪垫中引发了相同的乳腺癌特征,而皮下移植后这一结果受到干扰。在乳腺脂肪垫中形成的肿瘤对催乳素受体、孕激素受体、绿色荧光蛋白、Ki67、CD44、雌激素受体α/β和细胞角蛋白8表现出免疫反应性,而所有肿瘤及其衍生的原代细胞对雌激素受体α/β和细胞角蛋白8均表现出免疫反应性。癌症干细胞可以通过具有继承组织特异性能力的癌症衍生细胞的分泌因子从多能干细胞发育而来。然而,癌症干细胞应具有足够的可塑性以受特定组织微环境的影响。总之,我们成功地利用从小鼠正常成纤维细胞发育而来且未经基因操作的诱导多能干细胞建立了乳腺癌肿瘤模型。